BioLineRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.25	10.44	4.26	10.59	12.99
Short-Term Investments	17.63	9.13	38.74	40.5	44.15
Cash & Short-Term Investments	20.88	19.56	42.99	51.08	57.14
Cash Growth	6.72%	-54.50%	-15.83%	-10.59%	152.95%
Accounts Receivable	0.05	2.48	0.36	-	-
Other Receivables	0.41	1.48	0.83	0.72	0.14
Total Trade Receivables	0.46	3.95	1.19	0.72	0.14
Inventory	2.15	3.15	1.95	-	-
Other Current Assets	0.2	0.44	1.05	0.2	0.13
Total Current Assets	23.68	27.1	47.18	52	57.4
Net Property, Plant & Equipment	0.86	1.35	1.89	2.5	2.28
Other Intangible Assets	16.37	10.45	14.85	21.89	21.7
Total Assets	40.91	38.91	63.93	76.38	81.39
Accounts Payable	3.49	5.58	10.87	6.97	5.57
Accrued Expenses	1.74	3.13	3.35	1.74	1.23
Current Portion of Long-Term Debt	4.48	4.48	3.15	1.54	2.76
Current Portion of Leases	0.23	0.52	0.53	0.43	0.17
Unearned Revenue	-	-	12.96	-	-
Other Current Liabilities	2.17	1.69	11.93	-	-
Total Current Liabilities	12.12	15.41	42.78	10.68	9.72
Long-Term Debt	4.46	8.96	6.63	8.63	-
Long-Term Leases	0.98	1.08	1.29	1.73	1.73
Other Long-Term Liabilities	-	-	-	4.51	1.86
Total Long-Term Liabilities	5.44	10.04	7.92	14.86	3.59
Total Liabilities	17.56	25.45	50.7	25.54	13.3
Common Stock	73.43	38.1	31.36	27.1	21.07
Additional Paid-in Capital	347.19	376.61	373.89	355.15	353.48
Accumulated Other Comprehensive Income	-1.42	-1.42	-1.42	-1.42	-1.42
Retained Earnings	-401	-399.83	-390.61	-329.99	-305.04
Total Common Shareholders' Equity	18.2	13.46	13.22	50.84	68.09
Minority Interest	5.15	-	-	-	-
Shareholders' Equity	23.35	13.46	13.22	50.84	68.09
Total Liabilities & Equity	40.91	38.91	63.93	76.38	81.39
Total Debt	10.15	15.04	11.59	12.32	4.65
Net Cash (Debt)	10.73	4.52	31.4	38.76	52.48
Net Cash Growth	137.20%	-85.60%	-18.98%	-26.15%	252.17%
Net Cash Per Share	2.61	2.27	19.56	30.05	47.50
Book Value	18.2	13.46	13.22	50.84	68.09
Book Value Per Share	4.43	6.74	8.24	39.41	61.62
Tangible Book Value	1.83	3.01	-1.63	28.96	46.38
Tangible Book Value Per Share	0.44	1.51	-1.02	22.45	41.98

Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q